Research Site — Olive Branch, Mississippi

Research Site is a clinical research site located in Olive Branch, Mississippi, United States 38654.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site has participated in 13 clinical trials with 2 currently active.

Therapeutic areas: Hyperlipidemia, Primary Hyperaldosteronism, COPD (Chronic Obstructive Pulmonary Disease).

Sponsors: Amgen, AstraZeneca, Grace Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Olive Branch

Browse all research sites in Mississippi · View every site in Olive Branch

• Olive Branch Family Medical Center
• Pfizer Investigational Site
• GSK Investigational Site
• Local Institution
• Novo Nordisk Investigational Site
• 'Desoto Family Medical Center
• Olive Branch Family Medical
• Forest Investigative Site 1884
• Arthrosi Investigative Site (693)
• Lexicon Investigational Site
• Investigational Site Number 840033

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 13 clinical trials on record, with 2 currently active. Their work covers Hyperlipidemia, Primary Hyperaldosteronism, COPD (Chronic Obstructive Pulmonary Disease).

Is Research Site accredited by Crixeo Clinical Trials?

Research Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.